Steven Cohen’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
Other funds holding CLDX
KCM
BBA
Steven Cohen's CLDX Position: Q3 2026 in Review
Steven Cohen reduced its Celldex Therapeutics (CLDX) stake by 44% in Q3 2026, selling an estimated $1.98M and leaving 65,405 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2381.
Steven Cohen first reported a position in CLDX in Q1 2021 and has held it in 18 quarters since. The position peaked at $109M in Q4 2023. 249 funds tracked by Wall St. Rank hold CLDX as of Q3 2026.
- Steven Cohen held 65,405 shares of Celldex Therapeutics worth $2.12M as of Q3 2026.
- Steven Cohen sold 51,812 Celldex Therapeutics shares in Q3 2026, an estimated $1.98M.
- Celldex Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2381 holding.
- Steven Cohen first reported a position in Celldex Therapeutics in Q1 2021 and has held it in 18 quarters since.
- Steven Cohen's Celldex Therapeutics position peaked at $109M in Q4 2023.
- 249 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.